Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
…..bears take warning. Indeed so.
It wasn’t that long ago I would be pretty jazzed about big red numbers to greet me at the start of the day. Ever since Mnuchin fired up the PPT machines, though, red numbers are meaningless. The equity markets simply get bid up through the day. Just look at the /ES chart below:
A couple of beautiful head and shoulders patterns from companies selling you cigarettes:
Just a reminder that next week we finally kick in to the heavy part of the earnings season. I’m looking forward to having a market moved by actual corporate results instead of whatever some Fed official is yammering about. And you can see this for yourself at any time on our quarterly reports page.
Health and cannabis stocks top our list of charts to watch today.Amarin Corporation plc (AMRN) popped $1.12 to $15.03 Wednesday on 13.8 million shares, more than 1 1/2 times its average volume. The move followed a J.P. Morgan Healthcare conference presentation by the company, which markets a purified fish-oil pill. The stock took out the declining tops line and reached resistance at $15.80 before backing off. Next targets are $17 and then $19.
Aphria Inc. (APHA) gained 46 cents to $6.79 on 7.2 million shares Wednesday on no news. The cannabis stock popped across resistance, getting to as high as $6.90, important resistance from its gap down in early December. A move to fill that gap would get the stock to $7.75-$8.00, our next target.
(more…)
